Research ArticleToxicology
3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine
Yunden Jinsmaa, Yehonatan Sharabi, Patti Sullivan, Risa Isonaka and David S. Goldstein
Journal of Pharmacology and Experimental Therapeutics July 2018, 366 (1) 113-124; DOI: https://doi.org/10.1124/jpet.118.248492
Yunden Jinsmaa
Clinical Neurocardiology Section, Clinical Neurosciences Program/Division of Intramural Research/National Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, Maryland (Y.J., Y.S., P.S., R.I., D.S.G.), and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (Y.S.)
Yehonatan Sharabi
Clinical Neurocardiology Section, Clinical Neurosciences Program/Division of Intramural Research/National Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, Maryland (Y.J., Y.S., P.S., R.I., D.S.G.), and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (Y.S.)
Patti Sullivan
Clinical Neurocardiology Section, Clinical Neurosciences Program/Division of Intramural Research/National Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, Maryland (Y.J., Y.S., P.S., R.I., D.S.G.), and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (Y.S.)
Risa Isonaka
Clinical Neurocardiology Section, Clinical Neurosciences Program/Division of Intramural Research/National Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, Maryland (Y.J., Y.S., P.S., R.I., D.S.G.), and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (Y.S.)
David S. Goldstein
Clinical Neurocardiology Section, Clinical Neurosciences Program/Division of Intramural Research/National Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, Maryland (Y.J., Y.S., P.S., R.I., D.S.G.), and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (Y.S.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleToxicology
DOPAL-Induced Protein Modifications
Yunden Jinsmaa, Yehonatan Sharabi, Patti Sullivan, Risa Isonaka and David S. Goldstein
Journal of Pharmacology and Experimental Therapeutics July 1, 2018, 366 (1) 113-124; DOI: https://doi.org/10.1124/jpet.118.248492
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement